Capital Research Global Investors’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Capital Research Global Investors’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,154,180	Closed	-$29.9M	–	467
2021 Q3	$29.9M	Sell	1,154,180 -2,776,176	-71%	-$88M	0.01%	396
2021 Q2	$180M	Buy	3,930,356 +1,151,525	+41%	+$54.5M	0.04%	255
2021 Q1	$122M	Sell	2,778,831 -23,869	-0.9%	-$1.16M	0.03%	285
2020 Q4	$86.2M	Hold	2,802,700	–	–	0.02%	310
2020 Q3	$89.2M	Hold	2,802,700	–	–	0.03%	278
2020 Q2	$70.5M	Buy	+2,802,700	New	+$70.8M	0.02%	297

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors's AMTI Position: Q4 2021 in Review

Capital Research Global Investors sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q4 2021, closing a stake of 1,154,180 shares — an estimated $29.9M sold.

Capital Research Global Investors first reported a position in AMTI in Q2 2020 and held it in 6 quarters. The position peaked at $180M in Q2 2021. 83 funds tracked by Wall St. Rank hold AMTI as of Q4 2021.

Capital Research Global Investors reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Capital Research Global Investors sold 1,154,180 Applied Molecular Transport Inc. Common Stock shares in Q4 2021, an estimated $29.9M.
Capital Research Global Investors first reported a position in Applied Molecular Transport Inc. Common Stock in Q2 2020 and held it in 6 quarters.
Capital Research Global Investors's Applied Molecular Transport Inc. Common Stock position peaked at $180M in Q2 2021.
83 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2021.

Based on Capital Research Global Investors's 13F filing for Q4 2021, filed 14 Feb 2022.